Compound Detail
CHEMBL1677
TACRINE HYDROCHLORIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
10
Targets
37
Activities
3
Assay Types
23
PK Parameters
20
Publications
6
Known Names
1
Mechanisms
Molecular Properties
198.3
MW (Da)
2.70
ALogP
2
HBA
1
HBD
38.9
PSA (Ų)
0.71
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1993 |
| Availability | Discontinued |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cholinesterases; ACHE & BCHE inhibitor | INHIBITOR | Cholinesterases; ACHE & BCHE | ✓ | ✓ |
Activity Summary
IC50 34 meas. best 8.07
Ki 2 meas. best 7.0
EC50 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 8.07 | 7.805 | 8.4 | 2 |
| Cholinesterase CHEMBL5763 | IC50 | 7.97 | 7.77 | 10.6 | 2 |
| Butyrylcholinesterase CHEMBL5077 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Cholinesterase CHEMBL1914 | IC50 | 7.64 | 7.424 | 23.0 | 5 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 7.37 | 7.135 | 42.3 | 4 |
| Butyrylcholinesterase CHEMBL3403 | IC50 | 7.04 | 7.04 | 92.0 | 1 |
| Acetylcholinesterase CHEMBL220 | IC50 | 7.03 | 6.6325 | 93.0 | 8 |
| Acetylcholinesterase CHEMBL220 | Ki | 7.0 | 6.825 | 101.0 | 2 |
| Acetylcholinesterase CHEMBL4768 | IC50 | 6.89 | 6.89 | 130.0 | 3 |
| Acetylcholinesterase CHEMBL3199 | IC50 | 6.65 | 6.65 | 223.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.3 | 5.0571 | 5011.9 | 7 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 176.46 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 138.79 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 40.33 | mL.min-1.kg-1 | Homo sapiens |
| CL | 77.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 93.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 310.0 | nM | Rattus norvegicus |
| Cmax | 740.0 | nM | Rattus norvegicus |
| Cmax | 360.0 | nM | Rattus norvegicus |
| Cmax | 700.0 | nM | Rattus norvegicus |
| F | 17.0 | % | Homo sapiens |
| F | 29.0 | % | Rattus norvegicus |
| F | 27.0 | % | Rattus norvegicus |
| MRT | 1.1 | hr | Rattus norvegicus |
| MRT | 0.9 | hr | Rattus norvegicus |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 1.1 | hr | Rattus norvegicus |
| T1/2 | 0.9 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Rattus norvegicus |
| Vd | 5.02 | L.kg-1 | Homo sapiens |
| Vd | 5.2 | L.kg-1 | Rattus norvegicus |
| Vd | 5.1 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21148081 | 10.1124/dmd.110.035964 | Rattus norvegicus | 32 |
| 22512543 | 10.1021/jm300106z | Mus musculus | 8 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| 21148081 | 10.1124/dmd.110.035964 | Blood | 6 |
| 29466774 | 10.1016/j.ejmech.2018.01.028 | Mus musculus | 6 |
| 21148081 | 10.1124/dmd.110.035964 | Homo sapiens | 5 |
| 18517184 | 10.1021/jm8001313 | Acetylcholinesterase | 4 |
| 11741490 | 10.1021/jm010949b | Acetylcholinesterase | 3 |
| 22818849 | 10.1016/j.ejmech.2012.06.051 | Acetylcholinesterase | 3 |
| 17944454 | 10.1021/jm070859s | Acetylcholinesterase | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 21939219 | 10.1021/np200308j | Acetylcholinesterase | 2 |
| 10514292 | 10.1021/jm990224w | Acetylcholinesterase | 2 |
| 21148081 | 10.1124/dmd.110.035964 | Butyrylcholinesterase | 2 |
| 21148081 | 10.1124/dmd.110.035964 | Unchecked | 2 |
| 17944454 | 10.1021/jm070859s | Unchecked | 2 |
| 15771413 | 10.1021/jm0496741 | Acetylcholinesterase | 2 |
| 21148081 | 10.1124/dmd.110.035964 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
Data from ChEMBL 36 via Core Engine